Swk Holdings CORP 8-K filings
8-K: SWK Holdings Subsidiary Enters Exclusive Option Agreement with AptarGroup for Manufacturing Assets
SWK Holdings' subsidiary, Enteris Biopharma, has granted AptarGroup an exclusive option to acquire its GMP manufacturing and clinical supply assets, with potential for a multi-million dollar transaction.
SWK Holdings Corporation's Chief Financial Officer, Yvette Heinrichson, has resigned effective February 13, 2024, with the CEO assuming interim CFO duties.